Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
15,55 USD | +5,57% | +6,58% | -18,59% |
Attività
Numero di dipendenti: 577
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Immunotherapies
100,0
%
| 112 | 100,0 % | 117 | 100,0 % | +4,46% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 112 | 100,0 % | 117 | 100,0 % | +4,46% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Juan Jaen
FOU | Founder | 66 | 01/01/15 |
Terry Rosen
CEO | Chief Executive Officer | 64 | 01/01/15 |
Robert Goeltz
DFI | Director of Finance/CFO | 51 | 01/08/20 |
Dimitry Nuyten
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/22 |
Steve Young
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/16 |
Jennifer Jarrett
COO | Chief Operating Officer | 53 | 01/03/17 |
Chief Tech/Sci/R&D Officer | 55 | 01/01/20 | |
Eric Matthews
PRN | Corporate Officer/Principal | - | 24/06/19 |
Alexander Azoy
AUD | Comptroller/Controller/Auditor | 48 | 02/10/20 |
Carolyn Tang
LAW | General Counsel | 45 | 01/07/17 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Terry Rosen
CEO | Chief Executive Officer | 64 | 01/01/15 |
Kathryn Falberg
BRD | Director/Board Member | 63 | 18/09/17 |
Yasunori Kaneko
BRD | Director/Board Member | 69 | 01/05/15 |
Juan Jaen
FOU | Founder | 66 | 01/01/15 |
Merdad Parsey
BRD | Director/Board Member | 61 | 13/07/20 |
Antoni Ribas
BRD | Director/Board Member | 57 | 28/10/19 |
David Lacey
BRD | Director/Board Member | 71 | 21/05/20 |
Nicole Lambert
BRD | Director/Board Member | 50 | 03/08/21 |
Jennifer Jarrett
COO | Chief Operating Officer | 53 | 01/03/17 |
Johanna Mercier
BRD | Director/Board Member | 54 | 29/01 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 90 952 836 | 53 540 725 ( 58,87 %) | 0 | 58,87 % |
Coordinate società
Settore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-18,59% | 1,41 Mrd | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione RCUS
- Società Arcus Biosciences, Inc.